$MDCX +31% 🚀 🔹 Strong breakout as investors pile into this clinical-stage biotech focused on skin cancer treatments 📈 🔹 Lead program SKNJCT-003 is targeting

$MDCX +31% 🚀 🔹 Strong breakout as investors pile into this clinical-stage biotech focused on skin cancer treatments 📈 🔹 Lead program SKNJCT-003 is targeting non-melanoma skin cancer with a non-invasive treatment approach 🧬 🔹 Recent updates highlighted continued clinical progress and advancemen…